Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04684108
Title SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hangzhou Sumgen Biotech Co., Ltd.
Indications

multiple myeloma

hematologic cancer

chronic lymphocytic leukemia

non-Hodgkin lymphoma

Hodgkin's lymphoma

Therapies

SG301

Age Groups: adult | senior
Covered Countries


No variant requirements are available.